ERG11CYP51A

ERG11CYP51A is a fungal gene encoding lanosterol 14-demethylase, a member of the cytochrome P450 superfamily (CYP51). The enzyme catalyzes the 14α-demethylation of lanosterol, a crucial step in the biosynthesis of ergosterol, the primary sterol of fungal membranes. By enabling the production of ergosterol, ERG11CYP51A supports proper membrane structure and function in fungi.

The encoded protein is typically an endoplasmic reticulum-associated monooxygenase that requires a heme prosthetic group and NADPH as part of its catalytic cycle. It contains the characteristic P450 signatures, including the heme-binding motif centered on a cysteine that coordinates the iron of the heme. The enzyme is essential for most yeasts and filamentous fungi, though some species harbor paralogs or multiple ERG11/CYP51 family members with overlapping functions.

Genetically, many fungal species possess ERG11/CYP51A as a key gene for ergosterol synthesis. Some organisms have additional paralogs or alternative isoforms (for example, cyp51A and cyp51B in certain molds), which can complicate resistance patterns and regulation. An important area of study is the variation in ERG11CYP51A sequences and promoter regions that influence expression and drug binding.

Clinically, ERG11CYP51A is the primary target of azole antifungals, which inhibit demethylation of lanosterol and disrupt ergosterol biosynthesis. Resistance arises through mutations in the coding sequence that reduce drug affinity, promoter changes that increase expression, or upregulation of efflux mechanisms. Knowledge of ERG11CYP51A variants informs antifungal resistance monitoring and the development of new therapeutics.